Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2000, p. 4471-4477, Vol. 38, No. 12
School and Graduate Institute of Medical
Technology, College of Medicine, National Taiwan
University,1 and Departments of
Laboratory Medicine2 and
Pediatrics,3 National Taiwan University
Hospital, Taipei, and Department of Pediatrics, Changhua
Christian Hospital, Changhua,4 Taiwan, Republic
of China
Received 20 March 2000/Returned for modification 3 May
2000/Accepted 21 September 2000
The transmembrane glycoprotein NSP4 functions as a viral
enterotoxin capable of inducing diarrhea in young mice. It has been suggested that NSP4 may be a key determinant of rotavirus pathogenicity and a target for vaccine development. Twenty two G1P[6] rotaviruses from babies with and without diarrhea were comparatively analyzed along
with reference strains and another 22 Taiwanese human rotaviruses of G
and P combination types different from the G1P[6] type. The sequence
variations in the NSP4 genes were studied by direct sequencing analysis
of the amplicons of reverse transcription-PCR. Two genetic groups could
be identified in this analysis. While the majority of these strains
were closely related to the Wa strain, the G2 viruses were closely
related to the S2 strain. Furthermore, phylogenetic analysis of the
NSP4 gene among the G2 rotaviruses revealed three distinct lineages
associated with DS-1, S2, and E210, respectively, as has been reported
previously for the VP7 gene. However, we found no apparent correlation
in the deduced amino acid sequences corresponding to the proposed
enterotoxic peptide region between the rotaviruses recovered from
individuals with and without diarrhea. The NSP4 gene product being a
pathogenic determinant may not be a generalized phenomenon.
The rotavirus is one of the major
etiologic agents of diarrheal disease, affecting mainly infants and
young children (12). The rotavirus genome contains 11 segments of double-stranded RNA, and complete virus particles have a
triple-layered protein capsid. VP4 and VP7 are two major structural
proteins on the outer capsid. Among the group A rotaviruses, 14 G (VP7)
serotypes and at least 20 P (VP4) genotypes have been defined on the
basis of their reactivity with G serotype-specific neutralizing
antibodies and the sequence variations of VP4 gene, respectively
(8, 12).
The rotavirus genome also encodes five nonstructural proteins. The
nonstructural protein NSP4, which is encoded by gene segment 10 for
most strains of rotavirus, is a glycoprotein anchoring the membrane of
the endoplasmic reticulum (8). It has been demonstrated in
previous studies by these authors that NSP4 serves as an intracellular
receptor for double-layered rotavirus particles and interacts with
viral capsid proteins during viral morphogenesis (2, 23).
NSP4 has been proposed as a possible viral enterotoxin capable of
inducing diarrhea in young mice (3). Specifically, a peptide
consisting of amino acids (aa) 114 to 135 on NSP4 has been shown to
trigger a signal transduction pathway that increases intracellular
calcium levels in cells by mobilizing calcium from the endoplasmic
reticulum, thus stimulating chloride secretion (3, 7, 22).
Furthermore, amino acid changes in this region have been associated
with alterations in the toxigenic activity of NSP4 and virulence of
rotavirus (3, 27). Finally, antibodies against NSP4 might
diminish the frequency and severity of rotavirus diarrhea
(3). Thus, further study of NSP4 as a key pathogenic determinant of human rotavirus infections might justify it as a
suitable target for vaccine development (16).
In a previous study, we reported results of rotavirus surveillance in
the neonatal nursery of Changhua Christian Hospital (CCH), located in
the central part of Taiwan, Republic of China. Stool specimens from
every baby born from October 1994 to May 1995 were tested
(5). Rotaviruses with G1P[6] specificity were found to be
associated with these hospital-acquired infections (C. N. Lee,
C. C. Lin, C. L. Kao, and H. N. Chen, Abstr. Xth Int. Congr. Virol. Int. Union Microbiol. Soc., abstr. PW03-11, p. 102, 1996). While more than half of these rotavirus-positive neonates suffered from fever, diarrhea, or dehydration, a considerable proportion of the infected neonates remained well during this outbreak
(5). In this study, we analyzed the genetic sequence of the
NSP4 genes of the rotaviruses recovered from babies with and without
diarrhea. Other locally isolated human rotavirus strains with different
combinations of G and P types were also compared, along with reference strains.
Rotavirus samples.
All rotavirus samples used in this study
were collected from CCH in central Taiwan and from the National Taiwan
University Hospital (NTUH) located in the northern city of Taipei
(Table 1). These samples had been shown
to be rotavirus positive with enzyme-linked immunosorbent assay kits:
Test Pack Rotavirus (Abbott Laboratories, Chicago, Ill.) for CCH
samples and Rotaclone (Meridian Diagnostic, Cincinnati, Ohio) for NTUH
samples. Coinfection of these children with other enteric pathogens had
been ruled out by negative bacterial cultures and negative testing for
astrovirus (IDEIA Astrovirus; DAKO, Cambridgeshire, England) and for
adenovirus type 40/41 (Meridian Diagnostic). All the original fecal
samples contained sufficient rotavirus particles for the viral RNA to be made visual by silver staining after polyacrylamide gel
electrophoresis.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
NSP4 Gene Analysis of Rotaviruses Recovered from
Infected Children with and without Diarrhea
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Rotavirus strains used for NSP4 gene analysis
70°C.
RNA extraction and purification. Rotavirus RNA was extracted and purified from stool samples according to a procedure described previously (15). Rotavirus particles were concentrated and precipitated by adding ammonium sulfate (to a final concentration of 35% [wt/vol]) in 1 ml of clarified stool suspension. After thorough mixing, the precipitated rotavirus particles were sedimented at 10,000 × g for 30 min. The supernatant was then removed, and the pellet was suspended in 100 µl of TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA). The rotavirus particles were then lysed by adding 25 µl of 5× extraction buffer to achieve a final concentration of 0.02 M Tris-HCl (pH 7.4), 0.15 M NaCl, 0.01 M MgCl2, 1% sodium dodecyl sulfate, and 2% (wt/vol) Ficoll. The viral RNA was extracted with phenol-chloroform two or three times, depending on the clarity of the samples, and further purified with chromatographic cellulose fiber powder CF11 (Whatman, Springfield Mill, England) to remove the inhibitors present in stool samples (25). Fifty microliters of the RNA was mixed with 15 mg of CF11, 2.5 µl of 5 M NaCl, and 9.25 µl of 100% ethanol. The mixture was rotated for 90 min at 4°C, and the RNA bound to CF11 was pelleted and washed three times with 500 µl of ethanol-containing STE (0.1 M NaCl, 50 mM Tris-HCl [pH 7.0], 1 mM EDTA). Finally, the RNA was eluted from the CF11 by adding 300 µl of ethanol-free STE. After 5 min of centrifugation, the supernatant RNA was collected and precipitated with ethanol in the presence of 2.5 M ammonium acetate. The RNA pellet was washed and suspended in 20 µl of TE buffer.
RT-PCR amplification of NSP4 gene. Three microliters of purified rotavirus RNA were used as the template in the reverse transcription PCR (RT-PCR) mixture. This mixture contained 7% dimethyl sulfoxide 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.01% (wt/vol) gelatin, 1.5 mM MgCl2, 0.1% Triton-X-100, a 200 µM concentration of each of the deoxynucleoside triphosphates and a 200 mM concentration of each of the forward, 10BEG.16 (5'-TGTTCCGAGAGAGCGCGTG-3'; nucleotide 16 to 34), and reverse, 10END.722c (5'-GACCATTCCTTCCATTAAC-3'; nucleotide 722 to 740), primers (24, 27). This mixture was heated for 10 min at 97°C, cooled on ice for 5 min, and briefly centrifuged at full-speed in a Microcentrifuge (Eppendorf 5415C). Super RT (5 U; HT Biotechnology, Cambridge, England), Taq polymerase (1 U; HT Biotechnology), and human placental ribonuclease inhibitor (20 U; HT Biotechnology) were then added. The mixture was incubated in a thermal cycler (Model 480; Perkin-Elmer, Foster City, Calif.) at 42°C for 1 h, 30 cycles each at 95°C for 45 s, 49°C for 30 s, 72°C for 1.5 min, and one cycle at 72°C for 10 min. Fragments 725 bp in length were amplified. For sequencing, the PCR products were purified through QIAquick silica gel membrane (QIAGEN, Chatsworth, Calif.).
Cycle sequencing. The purified PCR product was sequenced by using the sequencing kit with fluorescent dye terminators (Perkin-Elmer) according to the manufacturer's instructions. The primers used for sequencing were 10BEG.16, 10END.722c, 10.374 (5'-ATGATTGATAAACTAACTAC-3'), and 10.394c (5'-GTAGTTAGTTTATCAATCAT-3'). The thermal cycling conditions were set as recommended by the manufacturer: 96°C for 30 s, 50°C for 15 s, and 60°C for 4 min for 25 cycles (model 480 thermocycler; Perkin-Elmer). The products were purified by ethanol precipitation and then suspended in the loading buffer (100% formamide and 25 mM EDTA [pH 8.0] mixed in a 5:1 ratio). Samples were heated at 95°C for 2 min and loaded onto a 4.75% polyacrylamide gel. The sequence data were collected by an automatic DNA sequencer (model ABI-373A; Perkin-Elmer). Each gene fragment was sequenced at least twice.
Analysis of sequences. The sequence data were analyzed by GeneWorks software (IntelliGenetics, Mountain View, Calif.). Phylogenetic analysis was performed using the neighbor-joining method and the Kimura two-parameter distance matrix listed in the MEGA analytical package (14). The following reference NSP4 sequences from standard reference strains (with GenBank accession numbers in parentheses) were used in comparison: 1076 (U59105), A28 (D01145), AU-1 (D89873), AU32 (D88830), E201 (U59106), E210 (U59107), FRV-1 (D89874), FRV64 (D88833), KUN (D88829), M37 (U59109), NCDV (X06806), OSU (D88831), RV3 (U42628), RV4 (U59108), RV5 (U59103), S2 (U59104), SA11 (K01138), ST3 (U59110), UK (K03384), VA70 (U83798), Wa (K02032), YO (AB008236).
Nucleotide sequence accession number. The NSP4 gene sequences determined in this study were deposited in the GenBank sequence database. Table 1 lists the assigned accession numbers, AF173179 to AF173214 and AF174298 to AF174304, for Taiwanese rotavirus samples. The accession number for DS-1 is AF174305.
| |
RESULTS |
|---|
|
|
|---|
Sequence analysis of NSP4 genes of neonatal rotaviruses. The nucleotide sequences of NSP4 gene were amplified by RT-PCR and were then sequenced. Excluding the primer sequences, a fragment of 687 bp was analyzed and compared. Of the 21 G1P[6] rotavirus strains collected from neonates admitted to the CCH in 1994 and 1995 (CH2 to CH624, Table 1), 5 were recovered from infants with diarrhea and 16 were from diarrhea-free infants. The nucleotide sequences of the NSP4 genes were highly similar, with a homology of greater than 99%. Only one other G1P[6] strain, TE56, collected from a neonate with diarrhea in NTUH in 1993, exhibited such similarity in its NSP4 gene.
Comparison of NSP4 genes from rotaviruses with different
combinations of G and P types.
The 22 local strains (7 G1P[8], 7 G2P[4], 5 G3P[8], and 3 G4P[8]) that contained variable
combinations of G and P types and were recovered from children with
acute gastroenteritis were compared for similarity of the NSP4 genes
(Table 1). The degrees of similarity in the nucleotide sequence of the
22 Taiwanese G1P[6] strains with these G1, G3, and G4 strains ranged
from 94.6 to 98.4%. The degrees of similarity of these Taiwanese
G1P[6] strains with the reference G1P[8] strain Wa were higher than
97.5%. With three P[6] reference strains (M37, RV3, and ST3), the
degrees of similarity ranged from 94.2 to 97.2%. The Taiwanese
G1P[6] strains differed more in their NSP4 gene from the G2P[4]
strains (TA3, TA26, TA34, TD7, TE68, TE83, and TF85), with degrees of
similarity lower than 84%. Comparisons of the samples representing the
most divergent sequences from different genotypes are summarized in
Table 2.
|
Phylogenetic analysis of NSP4 gene.
Phylogenetic analysis of
the NSP4 genes for all the Taiwanese strains along with the reference
human and animal strains revealed that all the neonatal G1P[6]
strains clustered together, forming a distinct lineage within a broader
cluster that includes all Taiwanese strains of G1P[8], G3P[8], and
G4P[8] types, as well as the human reference strains with G1 (Wa,
RV4, M37), G3 (RV3, YO), G4 (ST3, VA70), and G9 (AU32) specificities
(Fig. 1). Two G1P[8] strains, TA10 and
TD11, collected in 1981 and 1992, respectively, formed a distinct
lineage along with M37. Two G1P[8] strains, TA1 (1978) and TG59
(1995), which were recovered from different epidemics separated by 17 years, were closely related and formed one distinct lineage. The
G3P[8] strains of 1989 (TA371, TA372, and TA373) formed a separate
lineage from those of 1997 (TI23 and TI25). In the same phylogenetic
tree, all the G2 strains formed a totally separate cluster, in which
the TA3 strain was close to reference G2 strains RV5 and DS-1; TA26,
TA34, and TD7 clustered with S2; TE68, TE83, and TF85 clustered with
E210 and E201 (Fig. 1). None of the Taiwanese strains associated
closely with any of the human strains, A28, 1076, and AU1, or the
animal strains, FRV1, FRV64, NCDV, OSU, SA11, and UK, analyzed in this
phylogenetic tree.
|
Amino acid sequence alignment.
The deduced amino acid
sequences of the NSP4 genes of 44 Taiwanese strains were aligned with
the avirulent reference strains, M37 and RV3, and virulent reference
strains, S2 and Wa. In all the strains analyzed, the 2 N-linked
glycosylation sites (aa 8 and 18) and two cysteine residues (aa 63 and
71) were all conserved (Fig. 2).
The three hydrophobic domains (aa 7 to 21, 28 to 47, and 67 to 85) (8) were also mostly conserved. No discernible differences in the amino acid sequences of NSP4 were noted between the
GIP[6] strains recovered from unaffected neonates and those from the
diarrheal neonates. The G2 strains differed from all other strains by
more than 25 residues. Variations could be found in the regions of the
putative VP4 binding site (aa 112 to 146), double-layered particle
binding site (161 to 175), and the predicted amphipathic alpha-helix
(aa 93 to 133) (8). In the region proposed as a toxic
peptide (aa 114 to 135), however, all of the Taiwanese G1P[6] strains
shared the exact amino acid sequence as that of the M37 and Wa strains,
with a His residue at position 131 in lieu of a Tyr, as in all G2
strains.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, two genetic groups of the NSP4 gene could be recognized in these human rotaviruses from Taiwan. The majority of the rotavirus strains analyzed here were the non-G2 strains that were closely related to the non-G2 reference strains, such as Wa, YO, or ST3. The G2 strains were closely related to the S2 strain.
Neonates at CCH, when infected by G1P[6] viruses, showed a variable spectrum of clinical outcomes. Coinfection by other pathogens that might explain such variable clinical outcomes was unlikely because those diagnostic procedures used for other common causes of diarrhea, viral or bacterial agents, revealed no other likely sources of infection. Similarly, no differences in feeding methods or metabolic status between the babies with diarrhea and those without were found. Although not examined in this study, maternal antibodies to rotavirus might have a variable effect in protecting neonates from different strains of rotavirus (17, 19-21). Differences in the genetic background of these neonates might also affect the clinical outcome. This possibility needs to be further investigated.
The genetic comparisons of NSP4 revealed that genes from unaffected neonates were nearly identical to those from neonates and children with diarrhea. These results are consistent with those of other investigators (10) and suggest that the NSP4 gene may not be the only pathogenic determinant of rotavirus. This is also supported by studies in a mouse model (1), where it was suggested that the enterotoxigenic properties of NSP4 do not play a critical role in the pathogenesis of murine rotavirus diarrhea. In view of these findings, the possible selection of NSP4 as a target for vaccine development requires further scrutiny. As an alternative to NSP4, other rotavirus genes (VP3, VP4, VP7, NSP1, and NSP2) have also been associated with pathogenicity in various animal models (4, 9, 11). Further studies of these genes and NSP4 to delineate the molecular basis of rotavirus pathogenesis will be needed to develop effective control strategies.
The genetic divergence of the NSP4 genes between the two genetic groups exceeded 16%. The amino acid variations between the strains of these two genetic groups could be found in the proposed biologically important domains, the VP4 binding site and the double-layered particle binding site (8). It remains to be examined whether these variations would affect the biological role of NSP4. Previously, the NSP4 genes of human rotaviruses have been categorized into two main genetic groups by some investigators (6, 10, 13). Most human rotaviruses were categorized as group B, whereas G2 viruses, together with many animal rotaviruses, were categorized as group A (13). Kirkwood and Palombo suggested that the human G2 rotaviruses may have derived their NSP4 genes from different animal rotaviruses (13). In our phylogenetic tree of the NSP4 gene, the genetic relationships of human G2 rotaviruses were comparable to those in the phylogenetic tree of VP7 gene (26). Zao et al. in 1999 indicated that a Taiwanese G2 strain, TA3, recovered in 1981, was closely related to RV5 in its VP7 gene; thereafter, the G2 strains were closely related to S2 (26). Within the S2 lineage, the G2 strains (TE68, TE83, and TF85) responsible for the epidemic in 1993 were more closely related to E210. TE68, TE83, TF85, and E210 have all been reported as reassortants of rotavirus (18, 26). The similarity between VP7 and NSP4 genes in the phylogenetic trees may imply that the two genes coevolve in these G2 rotavirus reassortants.
In this study, the nucleotide sequence of the NSP4 genes was determined for 44 human rotavirus strains belonging to genotypes of several G and P combinations recovered from Taiwanese children with or without diarrhea. Results in this study demonstrate that the genetic relationships among strains from different epidemics can be resolved by phylogenetic analysis of this gene. NSP4 gene analysis provides further insight into the genetic relation among rotaviruses worldwide but so far has failed to reveal pathogenic correlates among rotaviruses of Taiwan origin.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Mei-Shang Ho for precious comments and advice on language usage.
We thank the National Science Council of the Republic of China for financially supporting this research under contract NSC88-2314-B002-257.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: School and Graduate Institute of Medical Technology, College of Medicine, National Taiwan University, No. 1, Chang-Te St., Taipei, Taiwan 100, Republic of China. Phone: 886-2-23123456, ext. 6905. Fax: 886-2-23711574. E-mail: cnalee{at}ha.mc.ntu.edu.tw.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Angel, J., B. Tang, N. Feng, H. B. Greenberg, and D. Bass. 1998. Studies of the role for NSP4 in the pathogenesis of homologous murine rotavirus diarrhea. J. Infect. Dis. 177:455-458[Medline]. |
| 2. |
Au, K. S.,
W. K. Chan,
J. W. Burns, and M. K. Estes.
1989.
Receptor activity of rotavirus nonstructural glycoprotein NS28.
J. Virol.
63:4553-4562 |
| 3. | Ball, J. M., P. Tian, C. Q. Y. Zeng, A. P. Morris, and M. K. Estes. 1996. Age-dependent diarrhea induced by a rotavirus nonstructural glycoprotein. Science 272:101-104[Abstract]. |
| 4. | Burke, B., and U. Desselberger. 1996. Rotavirus pathogenicity. Virology 218:299-305[CrossRef][Medline]. |
| 5. | Chen, H. N., P. H. Dennehy, W. Oh, C. N. Lee, M. L. Huang, and L. Y. Tsao. 1997. Outbreak and control of a rotavirus infection in a nursery. J. Formosan Med. Assoc. 96:884-889[Medline]. |
| 6. | Cunliffe, N. A., P. A. Woods, J. P. G. Leite, B. K. Das, M. Ramachandran, M. K. Bhan, C. A. Hart, R. I. Glass, and J. R. Gentsch. 1997. Sequence analysis of NSP4 gene of human rotavirus allows classification into two main genetic groups. J. Med. Virol. 53:41-50[CrossRef][Medline]. |
| 7. |
Dong, Y. J.,
C. Q. Y. Zeng,
J. M. Ball,
M. K. Estes, and A. P. Morris.
1997.
The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C mediated inositol 1,4,5-triphosphate production.
Proc. Natl. Acad. Sci. USA
94:3960-3965 |
| 8. | Estes, M. K. 1996. Rotaviruses and their replication, p. 1625-1655. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 9. | Greenberg, H. B., H. F. Clark, and P. A. Offit. 1994. Rotavirus pathology and pathophysiology. Curr. Top. Microbiol. Immunol. 185:255-283[Medline]. |
| 10. | Horie, Y., O. Masamune, and O. Nakagomi. 1997. Three major alleles of rotavirus NSP4 proteins identified by sequence analysis. J. Gen. Virol. 78:2341-2346[Abstract]. |
| 11. | Hoshino, Y., L. J. Saif, S. Y. Kang, M. M. Sereno, W. K. Chen, and A. Z. Kapikian. 1995. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology 209:274-280[CrossRef][Medline]. |
| 12. | Kapikian, A. Z., and R. M. Chanock. 1996. Rotaviruses, p. 1657-1708. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 13. | Kirkwood, C. D., and E. A. Palombo. 1997. Genetic characterization of the rotavirus nonstructural protein, NSP4. Virology 236:258-265[CrossRef][Medline]. |
| 14. | Kumar, S., K. Tamura, and M. Nei. 1993. MEGA: Molecular Evolutionary Genetic Analysis, version 1.01. The Pennsylvania State University, University Park, Pa. |
| 15. | Lee, C. N., C. L. Kao, H. C. Ning, H. L. Fuh, and C. Y. Lee. 1997. Identification of VP7 serotypes of human rotaviruses by enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction. Acta Paediatr. Taiwanica 38:454-462. |
| 16. | Nakagomi, O., and T. Nakagomi. 1996. Rotavirus vaccines: a perspective. Microbiol. Immunol. 40:701-709[Medline]. |
| 17. | Offit, P. A., and H. F. Clark. 1985. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J. Infect. Dis. 152:1152-1158[Medline]. |
| 18. |
Palombo, E. A.,
H. C. Bugg,
P. J. Masendycz,
B. S. Coulson,
G. L. Barnes, and R. F. Bishop.
1996.
Multiple-gene rotavirus reassortants responsible for an outbreak of gastroenteritis in central and northern Australia.
J. Gen. Virol.
77:1223-1227 |
| 19. | Sheridan, J. F., C. C. Smith, M. M. Manak, and L. Aurelian. 1984. Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11. J. Infect. Dis. 149:434-438[Medline]. |
| 20. |
Snodgrass, D. R.,
C. R. Madeley,
P. W. Wells, and K. W. Angus.
1977.
Human rotavirus in lambs: infection and passive protection.
Infect. Immun.
16:268-270 |
| 21. | Snodgrass, D. R., and P. W. Wells. 1978. Passive immunity in rotaviral infections. J. Am. Vet. Med. Assoc. 173:565-568[Medline]. |
| 22. |
Tian, P.,
Y. Hu,
W. P. Schilling,
D. A. Lindsay,
J. Eiden, and M. K. Estes.
1994.
The nonstructural glycoprotein of rotavirus affects intracellular calcium levels.
J. Virol.
68:251-257 |
| 23. | Tian, P., M. K. Estes, Y. Hu, J. M. Ball, C. Q. Y. Zeng, and W. P. Schilling. 1995. The rotaviral nonstructural glycoprotein NSP4 mobilizes Ca2+ from the endoplasmic reticulum. J. Virol. 69:5763-5772[Abstract]. |
| 24. | Ward, R. L., B. B. Mason, D. I. Bernstenin, D. S. Sander, V. E. Smith, G. A. Zandle, and R. S. Rappaport. 1997. Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene. J. Virol. 71:6267-6270[Abstract]. |
| 25. |
Wilde, J.,
J. Eiden, and R. Yolken.
1990.
Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions.
J. Clin. Microbiol.
28:1300-1307 |
| 26. | Zao, C. L., W. N. Yu, C. L. Kao, C. Y. Lee, and C. N. Lee. 1999. Sequence analysis of VP1 and VP7 genes suggests occurrence of a reassortant of G2 rotavirus responsible for an epidemic of gastroenteritis. J. Gen. Virol. 80:1407-1415[Abstract]. |
| 27. |
Zhang, M.,
C. Q. Y. Zeng,
Y. Dong,
J. M. Ball,
L. J. Saif,
A. P. Morris, and M. K. Estes.
1998.
Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence.
J. Virol.
72:3666-3672 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»